Page
%P
-
Article
Open AccessIdentification of the epigenetic reader CBX2 as a potential drug target in advanced prostate cancer
While localized prostate cancer (PCa) can be effectively cured, metastatic disease inevitably progresses to a lethal state called castration-resistant prostate cancer (CRPC). Emerging evidence suggests that ab...
-
Article
Open AccessThe emerging role of histone lysine demethylases in prostate cancer
Early prostate cancer (PCa) is generally treatable and associated with good prognosis. After a variable time, PCa evolves into a highly metastatic and treatment-refractory disease: castration-resistant PCa (CR...
